The global alzheimer’s therapeutics market is expected to reach USD 6.4 billion in 2024, according to a new report by Grand View Research. Some primary factors driving the market growth includes rising government initiatives in order to raise awareness levels among people.Growing knowledge about the Alzheimer’s disease (AD) and its high prevalence and incidence in developing economies... Continue Reading →